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Abstract. 
 
Naturally occurring sympathetic neuron 
death is the result of two apoptotic signaling events: 
one normally suppressed by NGF/TrkA survival sig-
nals, and a second activated by the p75 neurotrophin 
receptor. Here we demonstrate that the p53 tumor sup-
pressor protein, likely as induced by the MEKK-JNK 
pathway, is an essential component of both of these
apoptotic signaling cascades. In cultured neonatal
sympathetic neurons, p53 protein levels are elevated in 
response to both NGF withdrawal and p75NTR activa-
tion. NGF withdrawal also results in elevation of a 
known p53 target, the apoptotic protein Bax. Func-
tional ablation of p53 using the adenovirus E1B55K 
protein inhibits neuronal apoptosis as induced by either 
NGF withdrawal or p75 activation. Direct stimulation 
of the MEKK-JNK pathway using activated MEKK1 
has similar effects; p53 and Bax are increased and the 
subsequent neuronal apoptosis can be rescued by 
E1B55K. Expression of p53 in sympathetic neurons in-
dicates that p53 functions downstream of JNK and up-
stream of Bax. Finally, when p53 levels are reduced or 
absent in p53
 
1
 
/
 
2
 
 or p53
 
2
 
/
 
2
 
 mice, naturally occurring 
sympathetic neuron death is inhibited. Thus, p53 is an 
essential common component of two receptor-medi-
ated signal transduction cascades that converge on the 
MEKK-JNK pathway to regulate the developmental 
death of sympathetic neurons.
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N
 
aturally
 
 occurring neuronal death is an essential
component of neural development in which 
 
,
 
50%
of any given neuronal population is lost as a
mechanism for establishing appropriate neuron:target cell
connections (reviewed in Oppenheim, 1991). Sympathetic
neurons of the peripheral nervous system, which require
NGF for their survival (reviewed in Levi-Montalcini,
1987), have been a prototype for analysis of the mecha-
nisms regulating this event. During the first two postnatal
weeks, sympathetic neurons compete for limiting amounts
of target-derived NGF, which binds to and activates TrkA
tyrosine kinase receptors (Kaplan et al., 1991
 
a
 
,
 
b
 
; Klein et al.,
1991) on neuronal teminals, thereby mediating a retro-
grade neuronal survival signal (Campenot et al., 1982; Ric-
cio et al., 1997; Senger et al., 1997). Traditionally, it has
been thought that the absence of such a TrkA retrograde
signal was sufficient to cause rapid neuronal apoptosis
during developmental death. However, we have recently
shown that the lack of such a NGF/TrkA-mediated sur-
vival signal is, of itself, insufficient for appropriate sym-
pathetic neuron death. Instead, a second neurotrophin
receptor, p75NTR (Johnson et al., 1986; Radeke et al.,
1987), is required for this process; in the absence of
p75NTR, sympathetic neuron apoptosis is delayed both in
culture and in vivo (Bamji et al., 1998). Moreover, ligand-
mediated activation of p75NTR is sufficient to cause sym-
pathetic neuron apoptosis (Bamji et al., 1998). Thus, ap-
propriate developmental sympathetic neuron death occurs
when p75NTR is activated coincident with suboptimal
NGF/TrkA survival signals (reviewed in Miller and Kap-
lan, 1998). This convergent regulation of neuronal apopto-
sis provides a mechanism whereby sympathetic neurons
are able to recognize not only whether they are receiving
adequate amounts of NGF, but also whether or not they
are exposed to ÒinappropriateÓ neurotrophins, potentially
as a function of late or inappropriate target innervation.
The intracellular mechanisms responsible for transduc-
ing these receptor-mediated apoptotic cascades in sympa-
thetic neurons remain ill-defined, although activation of
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the JNK pathway occurs after both p75NTR activation
(Casaccia-Bonnefil et al., 1996; Bamji et al., 1998) and
NGF withdrawal (Estus et al., 1994; Ham et al., 1995) and,
in the case of NGF withdrawal, is a necessary early event
in the apoptotic pathway. Moreover, Bax is essential for
sympathetic neuron apoptosis both in culture and during
naturally occurring death in vivo (Deckwerth et al., 1996;
Easton et al., 1997). One protein that is known to regulate
transcription of Bax (Miyashita and Reed, 1995) and that
has been implicated in cellular apoptosis is the p53 tumor
suppressor protein (reviewed in Hainut, 1995; Jacks and
Weinberg, 1996; Levine, 1997). However, although p53
has been implicated in neuronal death in response to
DNA damage or cellular stress (Li et al., 1994; Sakhi et al.,
1994; Wood and Youle, 1995; Morrison et al., 1996; Xiang
et al., 1998), this protein has not previously been thought
to play a role in naturally occurring cell death nor has it
been shown to act downstream of death receptor activa-
tion or of the MEKK-JNK pathway.
In this regard, we have previously demonstrated that in-
creased expression of p53 was sufficient to cause sympa-
thetic neuron apoptosis in the presence of NGF (Slack et al.,
1996). On the basis of this observation, together with the
fact that Bax is essential for naturally occurring sympa-
thetic neuron death (Deckwerth et al., 1996; Easton et al.,
1997), we hypothesized that p53 was an essential compo-
nent of the signaling pathways causing sympathetic neuron
apoptosis either in response to NGF withdrawal and/or to
p75NTR activation. In this paper, we test this hypothesis,
and demonstrate that both p75NTR activation and NGF
withdrawal cause increased expression of p53, likely as a
consequence of activation of the MEKK-JNK (Derijard
et al., 1994; Yan et al., 1994) pathway, and that this conver-
gent regulation of p53 is essential for normal naturally oc-
curring sympathetic neuron death.
 
Materials and Methods
 
Primary Neuronal Cultures
 
Mass cultures of pure sympathetic neurons from the superior cervical gan-
glion (SCG)
 
1
 
 of postnatal day 1 rats were prepared as previously de-
scribed (Belliveau et al., 1997; Bamji et al., 1998). Neurons were plated on
rat tail collagen coated tissue culture dishes; 6-well plates for biochemis-
try, and 48-well plates for survival assays. Low density SCG cultures were
used for all of the survival assays; for the survival assays in NGF with-
drawal and p75 activation experiments, neurons were used at densities of
4,000Ð6,000 and 2,000Ð4,000 neurons per well of a 48-well plate, respec-
tively. For biochemistry, 
 
z
 
40,000Ð50,000 neurons were plated per well of
a 6-well dish. For all experiments not involving viral infection, neurons
were initially cultured for 5 d in the presence of 50 ng/ml NGF. At the end
of this 5 day selection, neurons were washed several times in neurotro-
phin-free media before addition of the new neurotrophin- or KCL-con-
taining media.
NGF for these experiments was purified from mouse salivary glands
(CedarLane, Hornby, ON). Two sources of recombinant human BDNF
(Amgen, Thousand Oaks, CA; Preprotech, Rocky Hill, NJ) were used for
these experiments; similar results were obtained with both, as discussed
previously (Bamji et al., 1998).
 
Virus Infections and Survival Assays
 
Six different recombinant adenoviruses were used for these experiments.
Two, those expressing E1B55K, the E1B55K mutant A262 (Yew et al.,
1990), and p53 (Slack et al., 1996) have been previously constructed and
described. We also constructed adenoviruses (Massie et al., 1995) express-
ing activated MEKK1 (Eilers et al., 1998), and Bcl-xl (Boise et al., 1993) in
the Ad5 backbone (Bett et al., 1994), which drives expression from the
CMV promoter. As a control for these viruses, we used a recombinant ad-
enovirus in the same Ad5 backbone expressing 
 
E. coli
 
 
 
b
 
-galactosidase, as
we have previously described (Slack et al., 1996; gift of Dr. Frank Gra-
ham, McMaster University, Hamilton, Ontario).
All recombinant adenoviruses were purified on CsCl gradients, as we
have previously described (Slack et al., 1996). Infectious titer was deter-
mined by plaque assay on 293 cells (Graham and Prevec, 1991).
For the experiments involving E1B55K rescue from NGF withdrawal,
neurons were cultured for 3Ð4 d in 50 ng/ml NGF, and then were infected
overnight with various mois of recombinant adenovirus in serum-free me-
dia containing 50 ng/ml NGF. The next day, the virus was removed, and
the cells were fed with fresh media containing 10 ng/ml NGF. The follow-
ing day, cells were washed free of NGF with 3-h-long washes in serum-
free, NGF-free media, and then were switched to media with or without
10 ng/ml NGF. 2 d later, neuronal survival was assessed. For the p75 acti-
vation experiments, the protocol was similar with the exception that, after
the washes to remove NGF, neurons were switched to media containing
50 mM KCl with or without 100 ng/ml BDNF for 2 d.
For the experiments with the activated MEKK1 or p53 adenoviruses,
neurons were plated at a density of 10,000Ð12,000 neurons/well in 48-well
plates (Falcon Plastics, Cockeysville, MD) with 20 ng/ml NGF. On the
fifth day of culture, medium was removed, the virus was added in a vol-
ume of 200 ul DMEM media (GIBCO-BRL, Gaithersburg, MD) contain-
ing 2 mM glutamine, 100 U/ml penicillin, 100 ug/ml streptomycin (all from
BioWhittaker, Walkersville, MD), and 10% FBS. After 16Ð18 h of infec-
tion, the virus-containing media was removed and was replaced with Ul-
traculture media containing 2 mM glutamine, 100 U/ml penicillin, 100 
 
m
 
g/ml
streptomycin, and 20 ng/ml NGF. Cultures were maintained for 48 h, washed
four times for one hour each with growth factorÐfree media, and then
switched into the same media containing various concentrations of NGF.
Survival assays were performed as previously described (Slack et al.,
1996; Bamji et al., 1998) using nonradioactive cell proliferation (MTT) as-
says (CellTitre 96; Promega Corp., Madison, WI). 50 
 
m
 
l of the MTT re-
agent was added to each well and left for 90 min followed by the addition
of 100 
 
m
 
l of solubilization solution to lyse the cells. Each condition was re-
peated in triplicate. In each assay, baseline (0% survival) was considered
to be 0 ng/ml NGF, and 10 ng/ml NGF was considered to be 100% sur-
vival, unless stated otherwise. All other conditions were related to these
values.
 
Western Blot Analysis
 
For biochemistry, sympathetic neurons were lysed in TBS lysis buffer
(Knusel et al., 1994) containing 137 mM NaCl, 20 mM Tris (pH 8.0), 1%
(vol/vol) NP-40, 10% (vol/vol) glycerol, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin,
0.2 
 
m
 
g/ml leupeptin, 1.5 mM sodium vanadate, and 0.1% SDS. Cells were
collected in cold PBS by gentle scraping to detach them from the collagen
substratum, were washed three times with the same buffer, and then were
resuspended in 50 to 100 
 
m
 
l of lysis buffer, followed by rocking for 10 min
at 4
 
8
 
C. After a 10 minute centrifugation, the lysates were normalized for
protein concentration using a BCA Protein Assay Reagent (Pierce Chem-
ical Co., Rockford, IL). Equal amounts of protein (10Ð50 
 
m
 
g) were then
boiled in sample buffer for 5 minutes and separated by SDS-PAGE. After
electrophoresis, proteins were transferred to 0.2 
 
m
 
m nitrocellulose for 1.5 h
at 0.6 Amps, and the membrane was washed three times with TBS. For all
antibodies, the membranes were blocked in 3% nonfat milk in TBST
(blotto) for 1.5 h at room temperature. The membranes were then incu-
bated overnight at 4
 
8
 
C with the primary antibodies in blotto: anti-p53
(Oncogene Neurosciences, Manhasset, NY), anti-p53 (Novacastra, Bur-
lingame, CA), anti-p21 (Transduction Laboratories, Lexington, KY), anti-
p27 (Transduction Laboratories), anti-Bad (Transduction Laboratories),
anti-Bcl2 (Transduction Laboratories), anti-Bclxl (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), anti-Bax (Santa Cruz Biotechnology), anti-E1B55K
antibody 2A6, anti-human c-myc (PharMingen, San Diego, CA), anti-
phosphothr183/tyr184JNK (New England Biolabs, Boston, MA; Derijard
et al., 1994), anti-phosphoser473Akt (New England Biolabs), anti-phos-
phothr183/tyr185Erk (Promega Corp.), anti-TrkA (RTA; gift of Dr. L.
Reichardt, University of California, San Francisco, CA; Weskamp and
Reichardt, 1991), anti-tyrosine hydroxylase (Chemicon Laboratories, Te-
mecula, CA), or anti-tubulin (Oncogene Neurosciences). After incubation
with the primary antibodies, membranes were washed four times with
 
1. 
 
Abbreviations used in this paper:
 
 PB, phosphate buffer; moi, multiplicity
of infection; SCG, superior cervical ganglion. 
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TBST over 40 min, and incubated with the secondary antibody for 1.5 h at
room temperature. The secondary antibodies (goat antiÐmouse or goat
antiÐrabbit HRP from Boehringer Mannheim GmhB, Mannheim, Ger-
many) were used at 1/10,000 dilution. After three washes with TBST, de-
tection was carried out using the ECL chemiluminescence reagent from
Amersham and XAR x-ray film from Kodak.
 
Analysis of p53
 
2
 
/
 
2
 
 Mice
 
Mice heterozygous for a targeted mutation in the p53 gene (Donehower et
al., 1992) were obtained from GenPharm International (Mountainview,
CA). p53
 
2
 
/
 
2
 
 mice were maintained in a C57Bl/6 background, as homozy-
gotes or heterozygotes. Progeny from p53
 
2
 
/
 
2
 
 
 
3
 
 p53
 
1
 
/
 
2 
 
or from p53 het-
erozygote crosses were screened for the mutant allele(s) using PCR. To
amplify the mutant allele, PCR was conducted for 35 cycles (94
 
8
 
C for 30 s,
55
 
8
 
C for 60 s, 72
 
8
 
C for 90 s) using the following oligonucleotides: GTGG-
GAGGGACAAAAGTTCGAGGCC for the 5
 
9
 
 end, and TTTACG-
GAGCCCTGGCGCTCGATGT for the 3
 
9
 
 end. This results in a 200 nu-
cleotide fragment in mutant mice and no product in wildtype mice. To
amplify the wild-type allele, the same oligonucleotide was used as the 5
 
9
 
primer and ATGGGAGGCTGCCAGTCCTAACCC was used as the 3
 
9
 
primer. This results in amplification of a 600 nucleotide fragment in het-
erozygote and wild-type mice, and no product in the p53
 
2
 
/
 
2
 
 mice.
For morphometric analysis, the SCG were removed and immersion-
fixed in 4% paraformaldehyde in phosphate buffer (PB) for 1 h to over-
night at 4
 
8
 
C. Ganglia were cryoprotected in graded sucrose solutions,
7-
 
m
 
m-thick sections were serially cut on a cryostat, and every section was
collected and thaw-mounted onto chrom-alum subbed slides. Slides were
stained with cresyl violet and morphometric analyses were performed us-
ing a computer-based image analysis system (Biocom, Paris, France).
Neuronal numbers were determined by counting all neuronal profiles with
nucleoli on every third section, as per Coggeshall (1984). This sampling
frequency (every 21 
 
m
 
m) ensures that neurons are not double counted,
since the average neuronal diameter does not exceed 21 
 
m
 
m in any of the
groups examined (Bamji et al., 1998). This method does not correct for
split nucleoli. Statistical results were expressed as the mean 
 
6 
 
SE of the
mean and were tested for significance by a one-tailed StudentÕs 
 
t
 
 test.
For TUNEL analysis, SCGs were dissected from p53
 
1
 
/
 
2 
 
and p53
 
1
 
/
 
1
 
littermates at postnatal day 7. Ganglia were fixed for 30 min in 4%
paraformaldehyde, cryoprotected in graded sucrose solutions, and 7-
 
m
 
m-
thick sections cut on a cryostat. Every third section was collected and
thaw-mounted onto chrom-alum subbed slides and TUNEL staining im-
mediately performed using the Boehringer-Mannheim in situ cell death
detection kit. The number of TUNEL-positive cells on every third section
was determined by fluorescence microscopy, and these numbers were
used to determine the total number of TUNEL-positive cells per ganglia.
Results were tested for significance by a one-tailed StudentÕs 
 
t
 
 test.
 
Results
 
p53 and Bax Are Elevated after NGF Withdrawal from 
Sympathetic Neurons
 
Previously, we have demonstrated that an increase in p53
levels is sufficient to cause sympathetic neuron apoptosis
in the presence of NGF (Slack et al., 1996). To determine
whether endogenous p53 protein levels were ever similarly
elevated during sympathetic neuron apoptosis, we cul-
tured sympathetic neurons from neonatal animals, a time
when developmental death of these neurons is ongoing.
Initially, we examined p53 during sympathetic neuron
apoptosis induced by NGF withdrawal; this apoptosis is
relatively slow, taking 
 
z
 
48 h, and is transcription-depen-
dent (Deckwerth and Johnson, 1993; reviewed in Johnson
and Deckwerth, 1993). Neurons were cultured for 5 d in
the presence of 50 ng/ml NGF, NGF was withdrawn, and
then the cellular levels of p53 were quantitated using
Western blots with anti-p53 at various timepoints post-
withdrawal (Fig. 1 
 
A
 
). This analysis revealed that p53 lev-
els were elevated approximately threefold by 16 h after
NGF withdrawal (Fig. 1 
 
A
 
). Elevation of p53 protein was
first observed at 12 h (data not shown), and was main-
tained until at least 36 h post NGF-withdrawal (Fig. 1 
 
A
 
).
Interestingly, this timecourse corresponds to the commit-
ment point, after which NGF-withdrawn sympathetic neu-
rons cannot be rescued from apoptotic death (Johnson
and Deckwerth, 1993). Thus, NGF withdrawal leads to an
increase in p53 levels that correlates with the timecourse
of commitment to an apoptotic death.
To determine whether this increase in p53 had func-
tional consequences, we examined the expression of a
well-characterized p53 transcriptional target, the cyclin-
dependent kinase p21 (El-Diery et al., 1993). Western blot
analysis of equal amounts of protein from sympathetic
neurons at various timepoints after NGF withdrawal re-
vealed that p21 levels were increased twofold by 16 h after
NGF withdrawal, and that this increase was maintained
for at least 36 h (Fig. 1 
 
B
 
). This increase was not specific to
Figure 1. p53 and its transcriptional targets, p21 and Bax, are in-
creased during NGF-withdrawal induced apoptosis of sympa-
thetic neurons. (AÐG) Western blot analysis of equal amounts of
protein derived from sympathetic neurons either maintained in
10 ng/ml NGF (NGF), or at various timepoints from 4 to 48 h af-
ter withdrawal of NGF (2NGF).Western blots were probed with
antibodies specific to p53 (A), p21 (B), p27 (C), Bad (D), Bcl-2
(E), Bax (F), or Bcl-xl (G). Note that p53, p21, p27, Bad, and Bax
all increase after NGF withdrawal, whereas Bcl-2 and Bcl-xl de-
crease. (H) Western blot analysis of equal amounts of protein de-
rived from sympathetic neurons either maintained in 20 ng/ml
NGF, or withdrawn from NGF for 12 h (0 NGF). Western blots
were probed with antibodies specific to phosphorylated forms of
Akt (P AKT) or ERKS (P Erks). Note that phosphorylation of
these TrkA targets was significantly decreased after NGF with-
drawal. 
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p21, since levels of p27, a second cyclin-dependent kinase
(Toyoshima and Hunter, 1994), were also increased ap-
proximately twofold at 24 and 36 h after NGF withdrawal
(Fig. 1 
 
C
 
).
We next investigated the levels of Bax, another tran-
scriptional target of p53 (Miyashita and Reed, 1995) that is
known to be essential for naturally occurring sympathetic
neuron death (Deckwerth et al., 1996; Easton et al., 1997).
Western blot analysis revealed that, like p53, Bax levels
increased approximately twofold after NGF withdrawal
(Fig. 1 
 
F
 
). This increase was first observed at 16 h, and lev-
els were maximal by 24 h (Fig. 1 
 
F
 
). Interestingly, Western
blot analysis revealed that a second proapoptotic member
of this family, Bad (Yang et al., 1995), was also increased
threefold after NGF withdrawal (Fig. 1 
 
D
 
). Like Bax, this
increase in Bad commenced at 
 
z
 
16 h after withdrawal, the
committment point for apoptosis. In contrast to Bad and
 
Figure 2.
 
E1B55K-mediated inhibition of p53 rescues sympa-
thetic neuron apoptosis as induced by NGF withdrawal (
 
A
 
),
p75NTR activation (
 
B
 
), and activated MEKK (
 
CÐE
 
). (
 
A
 
) p53
and NGF withdrawal-induced apoptosis. Sympathetic neurons
were infected in parallel with recombinant adenovirus expressing
E1B55K, the mutant E1B55K A262, or 
 
b
 
-galactosidase (
 
LacZ
 
) at
titers of 100 or 500 moi and NGF was withdrawn from the media
2 d later. After 48 h, cell survival was measured by MTT assays. 0
NGF represents uninfected sympathetic neurons that were also
withdrawn from NGF, whereas 10 NGF represents uninfected
sympathetic neurons maintained in the presence of 10 ng/ml NGF
for the course of the experiment. Results are those obtained in a
representative experiment performed in triplicate, and represent
the mean 
 
6 
 
the standard error. Similar results were obtained in
five separate experiments. ***Indicates those values that are sig-
nificantly different from the 0 NGF control (
 
P
 
 , 
 
0.005). Note
that only those neurons transduced with E1B55K were rescued
from NGF withdrawal-induced apoptosis. (
 
B
 
) p53 and p75-
induced apoptosis. Sympathetic neurons were infected with re-
combinant adenovirus expressing E1B55K or the mutant E1B55K
A262 at a titer of 500 moi and 2 d later were switched into 50 mM
KCl (
 
KCL
 
1
 
E1B55K
 
 
 
and 
 
KCL
 
1
 
A262
 
) or 50 mM KCl plus 100
ng/ml BDNF (
 
KCL
 
1
 
BDNF
 
1
 
E1B55K
 
 and 
 
KCL
 
1
 
BDNF
 
1
 
A262
 
). As controls, uninfected neurons were switched into 50 mM
KCl (
 
50 KCL
 
), into 50 mM KCl plus 100 ng/ml BDNF
(
 
KCL
 
1
 
BDNF
 
), or were withdrawn from NGF (
 
0 NGF
 
). After
48 h, cell survival was measured using MTT assays. Results are
those obtained in a representative experiment performed in trip-
licate, and represent the mean 
 
6 
 
standard error. Similar results
were obtained in four separate experiments. ***Indicates those
values that are significantly different from 50 mM KCl alone, and
(***) indicates those values amongst the points that received
BDNF that are significantly different from KCL
 
1
 
BDNF (
 
P
 
 ,
 
0.005). Note that, as previously reported (Bamji et al., 1998),
BDNF reduces neuronal survival in the presence of KCl, and that
E1B55K but not A262 is able to completely rescue this BDNF-
mediated apoptosis. (
 
C
 
) MEKK1-induced apoptosis. Sympathetic
neurons were infected with recombinant adenovirus expressing
activated MEKK1 or 
 
b
 
-galactosidase (
 
LacZ
 
) at concentrations of
20 to 200 moi, and were maintained in 20 ng/ml NGF for 4 d after
infection. As controls, uninfected neurons were maintained for
the entire experiment in 20 ng/ml NGF. Cell survival was mea-
sured using MTT assays, and results are those obtained in a rep-
resentative experiment performed in triplicate, and represent the
mean 
 
6 
 
standard error. Similar results were obtained in 4 sepa-
rate experiments. **Indicates those values that are significantly
different between MEKK1 and the 
 
b
 
-galactosidase control at a
given moi (P , 0.005). Note that activated MEKK1 decreases
sympathetic neuron survival in a concentration-dependent fash-
ion. (D) p53 and MEKK1-induced apoptosis. Sympathetic neurons
were infected with 50 moi of MEKK1 plus 500 moi of E1B55K
(MEKK 1 E1B55K), A262 (MEKK 1 A262) or b-galactosidase
(MEKK 1 LacZ), were maintained in 20 ng/ml NGF for 4 d after
infection, and survival was then measured using MTT assays. As
further controls, neurons were infected with 50 moi b-galactosi-
dase virus (20 NGF 1 50 LacZ) for the same time period, or were
withdrawn from NGF for the final two days. Results are those ob-
tained in a representative experiment performed in triplicate, and
represent the mean 6 standard error. Results are normalized so
that 0 NGF is 0% survival, and 20 ng/ml NGF plus 50 moi b-gal-
actosidase (20 NGF 1 50 LacZ) is 100% survival. Similar results
were obtained in three separate experiments. ***Indicates that
E1B55K significantly rescues MEKK1-induced killing of sym-
pathetic neurons (P , 0.005). (E) p53 in JNK-Bax cell death
pathway. Sympathetic neurons were infected with 50 moi of the
activated MEKK1 adenovirus (50 MEKK) plus or minus 50 moi
Bcl-xl (MEKK 1 Bcl-xl), 500 moi E1B55K (MEKK 1 E1B55K)
or 500 moi A262 (MEKK 1 A262) adenoviruses. As a control,
neurons were infected with 50 moi b-galactosidase adenovirus
(50 LacZ). 4 d after the initial infection, during which time neu-
rons were maintained in 10 ng/ml NGF, survival was measured
using MTT assays. Results are those obtained in a representative
experiment performed in triplicate, and represent the mean 6
standard error. Results are normalized so that 0 NGF is 0%, and
10 ng/ml NGF plus 50 moi b-galactosidase adenovirus is 100%
survival. ***Indicates those values that are significantly different
from MEKK alone (P , 0.005).Aloyz et al. p53 and Neurotrophin Signal Transduction 1695
Bax, Western blot analysis for the anti-apoptotic protein
Bcl-2 (Hockenberry et al., 1990) revealed that levels of
this protein were relatively constant over this timecourse,
decreasing slightly at 24 h and later. A similar decrease
was observed for another prosurvival member of this fam-
ily, Bcl-xl (Boise et al., 1993), which was decreased by 36 h
after NGF withdrawal (Fig. 1 G). Thus, these data indicate
(a) that two transcriptional targets of p53, p21 and Bax,
are increased after NGF withdrawal, and (b) that the bal-
ance of proapoptotic to prosurvival members of the Bcl2
family is significantly shifted after removal of NGF.
We also examined signaling proteins that are activated
in response to TrkA receptor activation, including the
ERKs (Virdee and Tolkovsky, 1995; Creedon et al., 1996)
and Akt, a serine/threonine kinase thought to play a key
role in promoting NGF-dependent sympathetic neuron
survival (Crowder and Freeman, 1998). Western blot anal-
ysis with an antibody specific to the phosphorylated form
of the serine/threonine kinase Akt revealed that, 12 h after
NGF withdrawal, phosphorylation of Akt was greatly re-
duced (Fig. 1 H). Western blot analysis with an antibody
specific to the phosphorylated form of the ERKs revealed
a similar decrease in the phosphorylation of these proteins
after NGF withdrawal (Fig. 1 H). Thus, NGF withdrawal
leads to a decrease in signaling via these TrkA-regulated
prosurvival pathways coincident with induction of poten-
tially proaptotic pathways.
Elevated p53 is Necessary for Sympathetic Neuron 
Apoptosis in Response to NGF Withdrawal
To determine whether this increase in p53 protein levels
was an essential component of the apoptotic cascade that
follows NGF withdrawal, we took advantage of the ade-
noviral E1B55K protein, which functionally ablates p53
(Yew et al., 1992). Specifically, neonatal sympathetic neu-
rons were cultured for 3Ð4 d in 50 ng/ml NGF, and then
were infected with one of two recombinant, replication-
defective adenoviruses; one of these adenoviruses ex-
pressed E1B55K while the second expressed a mutant
E1B55K protein (A262) that is defective in its ability to
bind and ablate p53 (Yew et al., 1990). As a further con-
trol, neurons were infected with a similar moi of recombi-
nant adenovirus expressing b-galactosidase (Slack et al.,
1996). 2 d after viral infection, neurons were washed free
of NGF and 2 d later, neuronal survival was measured us-
ing MTT assays (Fig. 2 A). These experiments demon-
strated that E1B55K, but not the E1B55K mutant A262 or
b-galactosidase, was able to rescue sympathetic neurons
from apoptosis. In 5 independent experiments, E1B55K
rescued 49% (100 moi) and 63% (500 moi) of the neurons
relative to those kept alive in 10 ng/ml NGF, increases
which were highly significant (P , 0.005 in both cases). In
none of these experiments did either the A262 or b-galac-
tosidase virus have a significant effect on neuronal survival
(Fig. 2 A).
To ensure that the effects of E1B55K were being medi-
ated via p53, we examined levels of p53 in NGF-with-
drawn sympathetic neurons after viral infection; the vector
used not only ablates p53 through the actions of E1B55K,
but also targets p53 for degradation through the adenovi-
ral E4orf6 product (Yew and Berk, 1992; Querido et al.,
1997; Teodoro and Branton, 1997). For these experiments,
sympathetic neurons were initially selected in 50 ng/ml
NGF for 3 d, were infected with the adenoviruses express-
ing E1B55K or the mutant E1B55K, and 2 d later were
withdrawn from NGF. As a control, neurons were not in-
fected or were infected with the b-galactosidase virus.
Analysis of p53 protein levels 36 h after this treatment re-
vealed that levels of p53 protein were similarly elevated in
NGF-withdrawn neurons that were uninfected, or that
were expressing either b-galactosidase or the mutant
E1B55K (Fig. 3 A). In contrast, p53 protein levels were
significantly reduced in the neurons expressing E1B55K,
as predicted. Reprobing of the same blot with an antibody
specific for the cytoskeletal protein tubulin confirmed that
equal amounts of protein were present in all of the sam-
ples (Fig. 3 B). Moreover, the differential effect of E1B55K
versus the A262 mutant was not due to a difference in lev-
els of expression of these two proteins, since the A262 pro-
Figure 3. E1B55K reduces p53 levels in sympathetic neurons
withdrawn from NGF. (A) Western blot analysis for p53 in sym-
pathetic neurons that were withdrawn from NGF for 36 h (0
NGF), that were maintained in 10 ng/ml NGF (10 NGF), or that
were infected with 500 moi of recombinant adenovirus expressing
A262 or E1B55K, and 2 d later were withdrawn from NGF for 24 h.
Equivalent amounts of protein from lysed neurons were electro-
phoresed, transferred to nitrocellulose filters, and p53 protein
levels were assessed using anti-p53. Note that p53 levels increase
after NGF withdrawal, and that expression of E1B55K reverses
this increase, while expression of A262 has no effect. (B) The
same blot as in panel (A) reprobed for the cytoskeletal protein
tubulin. (C) Western blot analysis for E1B55K using anti-
E1B55K in equal amounts of protein derived from sympathetic
neurons infected for 36 h with adenoviruses expressing E1B55K
or the E1B55K mutant A262. The antibody used for these studies
recognizes both the wild-type and mutant proteins. (D) Western
blot analysis for p53 in sympathetic neurons that were maintained
in 20 ng/ml NGF, and that were infected with 50 moi of recombi-
nant adenovirus expressing activated MEKK1 (MEKK) with or
without 200 moi of E1B55K for 36 h. Equivalent amounts of pro-
tein from lysed neurons were electrophoresed, transferred to ni-
trocellulose filters, and p53 protein levels were assessed using
anti-p53. (E) The same blot as in D reprobed for TrkA.The Journal of Cell Biology, Volume 143, 1998 1696
tein was expressed at higher levels than E1B55K (Fig. 3
C). These experiments therefore indicate that elevated
p53 protein levels are essential for NGF-withdrawal in-
duced apoptosis of sympathetic neurons.
p53 is Downstream of p75NTR and is Essential for 
p75NTR-mediated Neuronal Apoptosis
We have previously demonstrated that the immediate
early protein, c-jun, is hyperphosphorylated in sympa-
thetic neurons after p75NTR activation (Bamji et al.,
1998) as it is after NGF withdrawal (Estus et al., 1994;
Ham et al., 1995). To determine whether p53 elevation
was also a common downstream component of these two
apoptotic signaling cascades, we examined p53 levels in
sympathetic neurons in conditions where p75NTR activa-
tion leads to apoptosis. Specifically, for these experiments,
sympathetic neurons were cultured for 5 d in 50 ng/ml
NGF and then were switched to KCl, which maintains
sympathetic neuron survival in the absence of TrkA acti-
vation (Franklin et al., 1995). We then added the neurotro-
phin BDNF, which selectively binds p75NTR but not Trk
receptors on sympathetic neurons (Bamji et al., 1998), and
determined cellular p53 levels (Fig. 4 A). As seen with
NGF withdrawal, p53 levels were increased at 24 and 36 h
in neurons maintained in KCl plus BDNF relative to those
in KCl alone. Reprobing of the same blot with an antibody
to tyrosine hydroxylase revealed that equal amounts of
protein were present in all of the samples (Fig. 4 B). This
increase was already apparent at 12 h, a timepoint when
p53 levels were only first starting to increase after NGF
withdrawal (data not shown). Thus, p53 elevation is down-
stream of both p75NTR activation and NGF withdrawal.
To determine whether this increased p53 was essential
for p75NTR-mediated apoptosis, we performed rescue ex-
periments using the E1B55K adenovirus. Specifically, neu-
rons were cultured in 50 ng/ml NGF for 3Ð4 d, were in-
fected overnight with recombinant adenovirus, and 2 d
later were switched to media containing 50 mM KCl plus
or minus 100 ng/ml BDNF. Neuronal survival was then
measured after 48 h using MTT assays (Fig. 2 B). As we
have previously reported (Bamji et al., 1998), the addition
of BDNF to 50 mM KCl caused a decrease in sympathetic
neuron survival of z54% (Fig. 2 B). Expression of the mu-
tant E1B55K had no significant effect on this decrease (P 5
0.11). In contrast, expression of E1B55K rescued 100% of
the p75NTR-driven apoptosis (P 5 0.012; Fig. 2 B), a res-
cue similar to that observed for NGF-withdrawal induced
apoptosis. Thus, p53 elevation was an essential component
of the apoptotic cascades induced in cultured sympathetic
neurons by both NGF withdrawal and p75NTR activation.
p53 is Downstream of the MEKK-JNK Pathway, and Is 
Essential for MEKK-mediated Neuronal Apoptosis
These results indicated that the apoptotic cascades origi-
nating from NGF withdrawal and p75NTR activation
share two common components; hyperphosphorylation of
c-jun and p53 elevation. On the basis of these findings, we
hypothesized that p53 was downstream of the MEKK-
JNK pathway, which leads to c-jun hyperphosphorylation
(Derijard et al., 1994; Yan et al., 1994). To test this hypoth-
esis, we generated a recombinant adenovirus expressing
an activated form of MEKK1 which has previously been
shown to cause sympathetic neuron apoptosis and c-jun
hyperphosphorylation (Eilers et al., 1998). We first con-
firmed that this virus expressed the recombinant myc
epitope-tagged MEKK1 protein, and that it was capable of
activating the MEKK1 downstream target, JNK (Yan et
al., 1994), in sympathetic neurons. Specifically, sympa-
thetic neurons were grown in 20 ng/ml NGF for 4 d, were
infected with 20 moi of recombinant virus expressing acti-
vated MEKK1 or b-galactosidase, and then were analyzed
2 d later for expression of the myc-tagged MEKK1 on
Western blots with anti-myc (Fig. 5 A). Analysis of equal
amounts of protein from b-galactosidase versus MEKK1-
infected sympathetic neurons revealed the presence of a
myc-immunoreactive protein of the appropriate size, 35 kD,
in the MEKK1-infected neurons (Fig. 5 A). To confirm
that virally expressed MEKK1 was capable of activating
JNK, we performed similar experiments and then ana-
lyzed the lysates for phosphorylation of JNK using a phos-
pho-JNK antibody (Fig. 5 B). In this experiment, we com-
pared MEKK1-infected sympathetic neurons to sympathetic
neurons withdrawn from NGF, where JNK is known to be
activated (Eilers et al., 1998). Western blot analysis re-
vealed that the activated MEKK1 adenovirus caused
phosphorylation of JNK to the same level as did NGF
withdrawal, relative to neurons maintained in 10 ng/ml
NGF alone (Fig. 5 B).
We next determined whether adenovirus-mediated ex-
pression of activated MEKK1 was sufficient to cause sym-
pathetic neuron apoptosis, as was previously reported with
microinjection (Eilers et al., 1998). Specifically, neurons
were selected in 20 ng/ml NGF for 5 d, infected with vari-
ous concentrations of recombinant virus expressing acti-
vated MEKK1 or b-galactosidase, maintained in 20 ng/ml
NGF for a further 4 d, and then assayed for neuronal sur-
vival. Results from four separate experiments revealed
that activated MEKK1 led to neuronal apoptosis; at 20, 50,
or 100 moi, sympathetic neuron survival was decreased to
52, 54, and 44%, respectively, relative to neurons infected
Figure 4. p53 levels increase during
apoptosis of sympathetic neurons as
induced by BDNF-mediated activa-
tion of p75NTR. (A) Western blot
analysis for p53 in equal amounts of
protein derived from sympathetic
neurons that were cultured in 50 ng/
ml NGF for 4 d, and then were
washed free of NGF and switched
into 50 mM KCl (KCL), 50 mM
KCl plus 100 ng/ml BDNF (KCL 1
BDNF), or media containing no
NGF or KCl (0 NGF) for 24 or 36 h.
Note that p53 levels in the neurons
treated with KCl and BDNF are
similar to those in 0 NGF, and are
greater than those maintained in
KCl alone. (B) The same blot as in
A reprobed for the neurotransmit-
ter enzyme, tyrosine hydroxylase
(TH) to demonstrate that equal
amounts of protein were present in
each of the lanes.Aloyz et al. p53 and Neurotrophin Signal Transduction 1697
with the same concentration of b-galactosidase virus (Fig.
2 C). Similar results were obtained with neurons main-
tained in 10 ng/ml and 50 ng/ml NGF (data not shown).
We next determined whether activation of the MEKK-
JNK pathway caused elevation of p53 levels, as we had hy-
pothesized. Specifically, sympathetic neurons were main-
tained in 20 ng/ml NGF for 4 d, were infected with 20 or 50
moi of the activated MEKK1 adenovirus, and were then
maintained in 10 ng/ml NGF for a further 2 d before analy-
sis. To ensure that viral infection itself did not induce p53,
we infected sister cultures with the b-galactosidase adeno-
virus. Western blot analysis of equal amounts of protein
revealed that p53 levels were increased when sympathetic
neurons were infected with 20 or 50 moi of MEKK1 adeno-
virus, and that the magnitude of this increase was similar
to that observed after NGF withdrawal for 48 h (Fig. 5 C).
In contrast, no increase in p53 levels was seen upon infec-
tion with similar mois of the b-galactosidase adenovirus
(data not shown), consistent with the observation that this
latter virus had little or no effect on neuronal survival (Fig.
2 C). Thus, activation of the MEKK-JNK pathway led to
increased levels of p53 in the presence of NGF.
To determine whether p53 was an essential component
of the MEKK1-induced apoptotic signaling cascade, we
asked whether the E1B55K adenovirus could rescue the
apoptotic effects of activated MEKK1. To perform these
experiments, sympathetic neurons were cultured for 5 d in
20 ng/ml NGF, and were infected with 50 moi of the
MEKK1 virus plus or minus 500 moi of the E1B55K virus.
As a baseline for this study, we first determined whether
coinfection with E1B55K reduced the p53 levels induced
by activated MEKK1 alone (Fig. 3 D). Western blot analy-
sis of sympathetic neurons infected for 2 d revealed that
p53 protein levels were reduced in neurons expressing
E1B55K plus activated MEKK1 relative to those express-
ing MEKK1 alone (Fig. 3 D). Reprobing of the same blot
with an antibody specific for TrkA confirmed that equal
amounts of protein were present in all of the samples (Fig.
3 E).
To determine whether this reduction in p53 levels medi-
ated by E1B55K rescued sympathetic neurons from apop-
tosis induced by activated MEKK1, we performed similar
experiments and, 4 d after infection, MTT assays were per-
formed. As negative controls in this experiment, we used
adenoviruses expressing the mutant A262 protein or
b-galactosidase. Results of three separate experiments in-
dicated that the E1B55K adenovirus was able to signifi-
cantly rescue MEKK1-induced neuronal apoptosis (Fig. 2
D) relative to MEKK1 alone, or relative to MEKK1 plus
the b-galactosidase or A262 adenovirus (P  ,  0.005 for
E1B55K in all cases; Fig. 2 D). Thus, elevation of p53 pro-
Figure 5. (AÐD) p53 and Bax protein levels increase after activa-
tion of the MEKK-JNK pathway in sympathetic neurons. (A)
Western blot analysis for c-myc in equal amounts of protein de-
rived from sympathetic neurons infected with 20 moi myc-tagged
MEKK1 (20 moi MEKK) or b-galactosidase (control) adenovirus
for 48 h. In both cases, neurons were maintained in 20 ng/ml NGF
for the entirety of the experiment. (B) Western blot analysis for
phospho-JNK in equal amounts of protein derived from sympa-
thetic neurons that were infected with 50 moi MEKK1 adenovi-
rus and maintained for 48 h (50 moi MEKK), or from uninfected
sister cultures that were either maintained in 10 ng/ml NGF (10
NGF), or that were withdrawn from NGF for 48 h (0 NGF). Note
that the level of phospho-JNK immunoreactivity is similar in neu-
rons withdrawn from NGF or transduced with activated MEKK1.
(C) Western blot analysis for p53 in equal amounts of protein de-
rived from sympathetic neurons that were infected with 20 moi
MEKK1 adenovirus and maintained in 20 ng/ml NGF for 48 h (20
moi MEKK), or from uninfected sister cultures that were main-
tained in 10 ng/ml NGF (10 NGF), or that were withdrawn from
NGF for 48 h (0 NGF). Note that p53 protein levels are increased
by activated MEKK1 as they are by NGF withdrawal. (D) West-
ern blot analysis for Bax in equal amounts of protein derived
from sympathetic neurons that were infected with 50 moi
MEKK1 adenovirus and maintained in 20 ng/ml NGF for 48 h (50
moi MEKK), or from uninfected sister cultures that were main-
tained in 10 ng/ml NGF for the same time period. (E and F) In-
creased expression of p53 in sympathetic neurons causes in-
creased Bax protein, but does not affect phosphorylation of JNK.
(E) Western blot analysis for phospho-JNK in equal amounts of
protein derived from sympathetic neurons infected with 20 moi
p53 adenovirus and maintained in 20 ng/ml NGF for 48 h, or from
uninfected sister cultures that were maintained in 20 ng/ml for the
same time period. (F) Western blot analysis for Bax in equal
amounts of protein derived from sympathetic neurons infected
with 20 moi p53 adenovirus and maintained in 20 ng/ml NGF for
48 h, or from uninfected sister cultures maintained in 20 ng/ml
NGF for the same timeperiod. (G) Western blot analysis for p53
in equal amounts of protein derived from sympathetic neurons
maintained in 20 ng/ml NGF and infected with 20 moi p53 ade-
novirus or 50 moi activated MEKK adenovirus for 30 h. As a con-
trol, neurons were withdrawn from NGF (0 NGF) for 30 h.The Journal of Cell Biology, Volume 143, 1998 1698
tein levels is necessary for sympathetic neuron apoptosis
after activation of the MEKK-JNK pathway.
One potential downstream candidate for the apoptotic
effects of p53 in sympathetic neurons after MEKK-JNK
pathway activation is the proapoptotic protein Bax. To de-
termine whether Bax levels were increased in response to
the MEKK1 adenovirus as they were after NGF with-
drawal (Fig. 1 F), we selected sympathetic neurons for 4 d
in 20 ng/ml NGF, infected them with 50 moi of the
MEKK1 adenovirus, switched them into 10 ng/ml NGF
and 2 d later performed Western blots with anti-Bax. This
analysis revealed that Bax levels were increased approxi-
mately twofold in sympathetic neurons expressing acti-
vated MEKK1 (Fig. 5 D), an increase similar in magnitude
to that seen after NGF withdrawal (Fig. 1 F).
Previous studies have demonstrated that Bax is neces-
sary for sympathetic neuron apoptosis after NGF with-
drawal (Deckwerth et al., 1996). To determine whether
proapoptotic proteins like Bax are also necessary for sym-
pathetic neuron apoptosis after activation of the MEKK-
JNK pathway, we generated a recombinant adenovirus ex-
pressing a prosurvival member of this pathway, Bcl-xl
(Boise et al., 1993). Using this adenovirus, we then asked
whether altering the balance between prosurvival versus
proapoptotic members of this family could rescue MEKK1-
induced apoptosis. Specifically, sympathetic neurons were
cultured for 5 d, and were infected with 50 moi of the
MEKK1 adenovirus plus or minus various concentrations
of Bcl-xl virus. For comparison, neurons were infected
with 50 moi of MEKK1 virus plus 500 moi E1B55K or
A262. Neurons were then maintained in 20 ng/ml NGF for
four additional days before measuring survival using MTT
assays. This analysis revealed that the Bcl-xl adenovirus
was able to rescue the apoptotic effects of activated
MEKK1 at 20 (data not shown) or 50 moi (Fig. 2 E). A
similar rescue was observed with the E1B55K virus (Fig. 2
E), while no rescue was observed with the A262 virus (Fig.
2 E). Similar results were obtained when the MEKK1 ade-
novirus was used at 100 moi, although the magnitude of
the rescue effect with lower concentrations of Bcl-xl was
decreased (data not shown).
p53 Is Upstream of Bax and Downstream of JNK
These experiments demonstrated that JNK, p53 and Bax
are all downstream of activated MEKK, and that elevated
p53 is essential for MEKK-induced apoptosis. To deter-
mine whether p53 is downstream of JNK and upstream of
Bax, as we had hypothesized, we took advantage of a re-
combinant adenovirus expressing human p53 (previously
described in Slack et al., 1996). Specifically, sympathetic
neurons were cultured for 4 d in 20 ng/ml NGF, were in-
fected with 20 moi of p53-expressing adenovirus and 48 h
later, cell lysates were analyzed by Western blots with
anti-p53, anti-phosphoJNK or anti-Bax. This analysis re-
vealed that the p53 adenovirus increased expression of p53
to levels similar to those observed after NGF withdrawal
(Fig. 5 G), but that this elevated expression of p53 had no
effect on JNK phosphorylation in sympathetic neurons
maintained in 20 ng/ml NGF (Fig. 5 E). In contrast, infec-
tion with the p53 virus caused an increase in the levels of
Bax protein (Fig. 5 F) that was similar in magnitude to that
observed after NGF withdrawal (Fig. 1 F) or after infec-
tion with the activated MEKK1 adenovirus (Fig. 5 D).
Together with the previous experiments with activated
MEKK1, these experiments indicate that MEKK and JNK
are upstream of p53, while Bax is downstream (Fig. 7).
Figure 6. The number of sympathetic neurons in the superior
cervical ganglia is increased when p53 levels are decreased in
vivo. (A) Photomicrographs of cresyl-violet stained sections
through the SCG of wild-type (p531/1) versus p531/2 mice of
the same genetic background at postnatal day 15, when naturally
occurring sympathetic neuron death is complete. (B) Fluorescent
photomicrographs of in situ TUNEL labeling in the SCG of
p531/1 versus p531/2 mice of the same genetic background at
postnatal day 7, when developmental sympathetic neuron death
is ongoing. (C) The number of TUNEL-positive cells in the SCG
of P7 mice that are heterozygous (p531/2) or wild-type
(p531/1) for a p53 mutation created by homologous recombi-
nation (Donehower et al., 1992). Results are expressed as the
mean 6 standard error of the total number of TUNEL-positive
cells per SCG (n 5 5 for p531/2 and n 5 4 for p531/1). **Indi-
cates that these two values are significantly different (P 5 0.016).
(D) The number of neurons in the SCG of P1 or P15 mice that
are either p531/1 (control), or heterozygous (p531/2) or ho-
mozygous (p532/2) for the p53 mutant allele. Results are ex-
pressed as the mean 6 standard error (n 5 3 for P1 p531/1, 5 for
P1 p531/2, 3 for P1 p532/2, 5 for P15 p531/1, 6 for P15 p531/2
and 3 for P15 p532/2). **Indicates values significantly different
from p531/1 SCG of the same age (P , 0.05). Note that while
there is a statistically significant loss of 45% of the neurons in the
p531/1 SCG over this time period (**P , 0.05), there is no sig-
nificant loss of neurons in either the p531/2 or p532/2 SCG
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p53 is Essential for Naturally Occurring Sympathetic 
Neuron Death In Vivo
Our previous work indicates that naturally occurring sym-
pathetic neuron death is a result both of suboptimal acti-
vation of the TrkA receptor and of coincident activation
of p75NTR (Bamji et al., 1998). Since, in culture, both of
these types of neuronal apoptosis require p53, we hypoth-
esized that p53 would also be essential for sympathetic
neuron death in vivo. To test this hypothesis, we examined
the SCG of transgenic mice in which the p53 gene was de-
leted by homologous recombination (Donehower et al.,
1992). In control mice, the SCG contains z20,000Ð25,000
neurons at birth, depending on the genetic background.
Over the ensuing two weeks approximately half of these
neurons are lost so that by P15, control SCGs contain
z13,000 neurons (Bamji et al., 1998). We therefore chose
to analyze the SCG from p531/1, p531/2 and p532/2
mice at two timepoints; postnatal days 1 and 15, time-
points immediately preceding and after the normal period
of naturally occurring cell death (Fig. 6, A and D).
Analysis of the SCG at postnatal day 1 revealed that
sympathetic neuron numbers before the period of natu-
rally occurring death were similar regardless of the pres-
ence or absence of p53 (Fig. 6 D). The SCG of p531/1 an-
imals contained 23,976 6 2764 neurons (n 5 3), a number
similar to mice of other genetic backgrounds (Bamji et al.,
1998), while those from p531/2 and p532/2 animals con-
tained 20,537 6 2514 (n 5 5) and 19016 6 2675 (n 5 3), re-
spectively (Fig. 6 D). All of these numbers were statisti-
cally similar (P . 0.1 for all comparisons). However,
analysis of the SCG from animals of these same genotypes
at P15 (Fig. 6, A and D), after the period of naturally oc-
curring death, revealed significant differences. In control
p531/1 animals the P15 SCG contained 13,163 6 875 neu-
rons (n 5 5; Fig. 6 D). In contrast, the SCG of p531/2 an-
imals contained 20,352 6 944 neurons (n 5 6), and that of
p532/2 mice contained 20,600 6 1709 neurons (n 5 3),
statistically significant increases of 55 and 56%, respec-
tively (P , 0.005 in both cases). A comparison within the
same genotype from P1 to P15 revealed that while the
p531/1 ganglia lost z45% of its sympathetic neurons
over this timeframe (P , 0.05; Fig. 6 D), there was no sig-
nificant loss of sympathetic neurons in either the p531/2
or p532/2 SCG over the same period (Fig. 6 D; P . 0.3).
To confirm that this difference in neuron number in the
SCG during the period of naturally occurring cell death re-
flected a deficit in apoptosis in the p531/2 and p532/2
mice, and was not due to an increase in the proliferation of
neuronal progenitors that occurs for a short period postna-
tally in the SCG (Hendry, 1977), we analyzed the total
number of apoptotic cells in the SCG at postnatal day 7,
when sympathetic neuron apoptosis is ongoing. To per-
form this analysis, SCG from p531/2 and p531/1 litter-
mates were sectioned, and every third section was ana-
lyzed by in situ TUNEL-labeling. This analysis revealed
that TUNEL-positive cells were detected in the ganglia of
both p531/2 and p531/1 animals (Fig. 6 B), but that the
total number of apoptotic nuclei was significantly de-
creased in the p531/2 ganglia (p531/2 SCG, mean 5
661 6 19, n 5 5; p531/1 SCG, mean 5 1025 6 155, n 5 4;
P 5 0.016; Fig. 6 C). Thus, the magnitude of sympathetic
neuron apoptosis is decreased when p53 levels are de-
creased in vivo.
Discussion
In this study, we have examined the role of the p53 tumor
suppressor in naturally occurring sympathetic neuron
death. Our findings support an essential role for p53 in this
process and, more specifically, support the following con-
clusions. First, after NGF withdrawal of neonatal sympa-
thetic neurons, p53 levels are increased with a timecourse
that is consistent with it playing a role in the Òcommit-
mentÓ to apoptosis. The magnitude of this increase is simi-
lar to that required to induce sympathetic neuron apopto-
sis using adenovirus-mediated transduction of p53 (Slack
et al., 1996). Second, levels of two p53 transcriptional tar-
gets, p21 and Bax, are also increased; the latter of these
two, Bax, has already been shown to be essential for sym-
pathetic neuron apoptosis after NGF withdrawal (Deck-
werth et al., 1996). Third, p53 levels are also increased when
sympathetic neuron apoptosis is induced by p75NTR acti-
vation, with a similar timecourse to that observed after
NGF withdrawal. Fourth, a decrease in levels of p53 me-
diated by the E1B55K protein is sufficient to inhibit sym-
pathetic neuron apoptosis induced either by NGF with-
drawal or by p75NTR activation, indicating that increased
p53 levels are both necessary and sufficient (Slack et al.,
1996) for sympathetic neuron apoptosis. Fifth, NGF with-
drawal and p75NTR activation may induce apoptosis via a
pathway involving MEKK-JNK-p53-Bax (Fig. 7) since (a)
expression of activated MEKK1, which is sufficient to
cause sympathetic neuron apoptosis, leads to elevated lev-
els of p53 and Bax, (b) expression of p53 leads to elevated
Bax levels, but does not affect JNK activation, and (c) ele-
vated p53 is essential for MEKK-induced apoptosis. Fi-
nally, the physiological relevance of these observations is
indicated by our findings that, when p53 is reduced or ab-
sent, naturally occurring sympathetic neuron death is in-
hibited in vivo. Thus, our data indicate that p53 is a com-
mon, essential target during developmental sympathetic
neuron death that is downstream of the MEKK-JNK path-
way and that may well integrate apoptotic signals deriving
both from p75NTR activation and from a lack of NGF/
TrkA receptor activation.
The p53 tumor suppressor protein encodes a transcrip-
tional regulator that functions to control cell proliferation
and apoptosis in a cell context-dependent fashion (re-
viewed in Levine, 1997; Jacks and Weinberg, 1998). The
precise mechanism by which p53 mediates apoptosis is not
well understood, but it is believed to proceed by a number
of mechanisms including direct transactivation, transcrip-
tional repression, and direct involvement in DNA cleav-
age (Lane, 1993; Caelles et al., 1994; Elledge and Lee,
1995; Miyashita and Reed, 1995). Within the nervous sys-
tem, p53 is upregulated in neurons after a number of trau-
matic insults, including kainic acid and ischemia (Li et al.,
1994; Sakhi et al., 1994; Wood and Youle, 1995), and is
necessary for excitotoxicity-induced apoptosis of hippo-
campal and cortical neurons (Morrison et al., 1996; Xiang
et al., 1998). However, p53 has not been thought to be in-
volved in naturally occurring neuronal cell death, nor has
it been thought to be an essential downstream effector ofThe Journal of Cell Biology, Volume 143, 1998 1700
death receptor activation. In particular, a number of previ-
ous studies have failed to implicate p53 in sympathetic
neuron death. In one study, Martinou et al. (1995) dem-
onstrated that microinjection of the adenoviral protein
E1B19K, but not E1B55K, rescued sympathetic neurons
from apoptosis due to NGF withdrawal. The inability to
rescue sympathetic neuron apoptosis with microinjected
E1B55K as opposed to adenovirally expressed E1B55K is
likely due to the lower levels of expression obtained using
microinjection. In this regard, we have ourselves com-
pared the rescue of sympathetic neurons using adenovi-
rally expressed E1B19K versus E1B55K, and E1B19K was
able to rescue sympathetic neurons at titers z10-fold
lower than those needed for E1B55K (Pacquet, L., F.
Miller, and D. Kaplan, unpublished data). In a second set
of studies, cultured p532/2 sympathetic neurons died af-
ter NGF withdrawal, leading to the conclusion that p53
played no role in developmental sympathetic neuron
death (Davies and Rosenthal, 1994; Sadoul et al., 1996).
The studies presented here demonstrate that neurons with
lowered p53 levels still die in vivo, although the magnitude
of this death is significantly lower than in controls; these
results do not necessarily contradict the finding that
p532/2 neurons die in culture after NGF withdrawal.
Moreover, results might also differ in response to acute
inhibition of p53 (as mediated via E1B55K) versus a
chronic loss of p53 (as in p532/2 mice). For example, the
developmental absence of p53 may well cause compensa-
tory upregulation of parallel apoptotic pathways. Prece-
dent for such compensation derives from our previous
studies with another tumor suppressor protein, pRb. In
Rb2/2 mice, cortical neurons are unable to differentiate
appropriately and, as a consequence, undergo neuronal
apoptosis in vivo (Slack et al., 1998). However, when the
same Rb2/2 cortical progenitors are cultured and un-
dergo the transition to postmitotic neurons in vitro, they
differentiate normally and do not undergo apoptosis (Slack
et al., 1998); this difference is explained by a selective up-
regulation of p107 and p130, two other Rb family mem-
bers, in culture but not in vivo (Ruth Slack, personal com-
munication). A similar explanation could be invoked for
cultured p532/2 neurons; sympathetic neurons express
p73 (Pozniak, C., and F. Miller, unpublished data), an
apoptotic p53 family member (Jost et al., 1997; Kaghad et
al., 1997) that might well compensate for the lack of p53 in
a mutant p53 background.
What is the signal transduction pathway that derives ei-
ther from p75NTR activation or from a lack of activation
of TrkA and that leads to increased p53? Our data impli-
cate the MEKK-JNK pathway (Derijard et al., 1994; Yan
et al., 1994; Fig. 7). This pathway is activated in sympa-
thetic neurons in response to either NGF withdrawal
(Ham et al., 1995; Eilers et al., 1998) or p75NTR activation
(Bamji et al., 1998), and the resultant hyperphosphoryla-
tion of c-jun is necessary for NGF-withdrawal induced
sympathetic neuron death (Estus et al., 1994; Ham et al.,
1995). The data presented here indicate that activation
of the MEKK-JNK pathway causes sympathetic neuron
death via a p53-dependent mechanism, thereby providing
a potential direct link from p75 to p53. Moreover, our
finding that the stress-induced (Herdegen et al., 1997)
MEKK-JNK pathway acts via p53 in neurons may explain
why excitotoxicity-induced death of CNS neurons can be
inhibited by deletion of either the JNK3 (Yang et al.,
1997) or p53 genes (Morrison et al., 1996; Xiang et al.,
1998).
Are there other pathways that cause elevated p53 after
NGF withdrawal or p75NTR activation? A second candi-
date upstream pathway involves deregulation of the cell
cycle; in cycling cells, p53 is viewed as a Òfail-safeÓ mecha-
nism that causes cellular apoptosis when proliferative
mechanisms are deregulated (reviewed in Levine, 1997;
Jacks and Weinberg, 1996). Such cell cycle deregulation
has been proposed to occur in sympathetic neurons after
NGF withdrawal (Rubin et al., 1993; Freeman et al., 1994;
Park et al., 1997). Therefore, it is possible that NGF with-
drawal causes two different signals, MEKK-JNK activa-
tion and cell cycle deregulation, that together converge on
p53. Thus, p53 may function as a sensor to induce neu-
ronal apoptosis when the sum of these upstream signals
reaches a critical level.
What are the downstream events that are responsible
for p53-mediated neuronal apoptosis? One potential down-
stream mechanism involves the protein Bax, which is
known to be essential for sympathetic neuron apoptosis
(Deckwerth et al., 1996), and for p53-dependent death of
cortical neurons (Xiang et al., 1998). Data presented here
indicate that, after the commitment of sympathetic neu-
rons to apoptosis, the balance of proapoptotic versus pro-
survival members of the bcl-2 family is considerably
shifted to the proapoptotic, and that one of the changes
contributing to this shift is an increase in Bax protein lev-
els. Moreover, we demonstrate that increased expression
of p53 alone is sufficient to cause increased Bax protein
levels in sympathetic neurons. Since Bax is a direct tran-
Figure 7. Model of sympa-
thetic neuron apoptosis in-
duced by NGF withdrawal or
p75NTR activation. Both of
these apoptotic stimuli in-
crease p53 and Bax protein
levels, and require elevated
p53 levels to efficiently pro-
mote cell death. Neuronal
death induced by activated
MEKK1 also increases p53
and Bax protein levels, and
requires elevated levels of
p53 protein. NGF with-
drawal-mediated sympathe-
tic neuron death increases
JNK and c-jun phosphoryla-
tion and activity, and requires c-jun (Estus et al., 1994; Ham et al.,
1995). p75NTR activation in sympathetic neurons also leads to
hyperphosphorylation of c-jun, presumably via JNK (Bamji et al.,
1998). Bax is also essential for sympathetic neuron apoptosis in
vivo and in vitro (Deckwerth et al., 1996; Easton et al., 1997). The
precise MEKK or JNK family member in these pathways is not
known, and other intermediate proteins, such as SEK1 (Sanchez
et al., 1994) are likely involved as intermediate steps in this hypo-
thetical cascade. Moreover, although this model shows JNK sig-
naling to p53 via c-jun, recent work indicates that JNK can di-
rectly interact with and phosphorylate p53 (Hu et al., 1997). p53
may induce death by increasing Bax protein or activity, or via
other p53 target proteins (Polyak et al., 1997).Aloyz et al. p53 and Neurotrophin Signal Transduction 1701
scriptional target of p53 (Miyashita and Reed, 1995), we
propose that elevated p53 protein levels cause increased
p53-dependent transcription of Bax, and that this is suffi-
cient to tip the balance towards neuronal apoptosis. In
support of this hypothesis, exogenous p53 is unable to me-
diate apoptosis of Bax2/2 cortical neurons (Xiang et al.,
1998), Bax2/2 sympathetic neurons do not undergo apop-
tosis in response to NGF withdrawal (Deckwerth et al.,
1996), and increased expression of Bcl2 or Bcl-xl (Garcia
et al., 1992; Gonzalez-Garcia et al., 1995) in sympathetic
neurons rescues NGF withdrawal induced cell death.
The in vivo data presented here support a number of ad-
ditional conclusions. First, our studies demonstrate that
the postnatal period of naturally occurring sympathetic
neuron death is inhibited, but not completely eliminated
when p53 levels are lowered, indicating that p53 is essen-
tial for normal apoptosis in the SCG, but also suggesting
that other, potentially parallel death pathways are impor-
tant. Such pathways may involve other p53 family mem-
bers such as p73 (Jost et al., 1997; Kaghad et al., 1997) or
p51 (Osada et al., 1998; Trink et al., 1998). Second, our
data showing decreased apoptosis in the p531/2  SCG
support the idea that it is not the presence or absence of
p53 that determines apoptosis, but it is instead the levels of
p53 that are important. Precedent for such a gene dosage
effect has been documented with regard to p53 and tumor-
igenesis (Donehower et al., 1992; Harvey et al., 1993).
Third, our in vivo data demonstrate that, although p53
may be essential embryonically for regulating the prolifer-
ation and survival of sympathetic neuroblasts (Vogel and
Parada, 1998), that by birth any resultant deficits are not
obvious, since neuron numbers in the newborn p531/1
versus p532/2 SCG are not significantly different.
What is the biological rationale for p53 acting as a
ÒthresholdÓ to neuronal apoptosis? During the period of
naturally occurring death, sympathetic neurons compete
for limiting amounts of trophic support to ultimately en-
sure an appropriate target innervation density. The net re-
sult of this competition is a loss of z40Ð50% of sympa-
thetic neurons over the first 2 wk of postnatal life. Our
previous data indicate that both TrkA and p75NTR are re-
quired for this process (Bamji et al., 1998). Moreover,
these same studies demonstrate that robust activation of
TrkA antagonizes p75NTR-derived apoptotic signals and
that, conversely, p75NTR can override TrkA-derived sur-
vival signals. On the basis of the current study, we propose
that p53 is a convergent downstream target that ÒsumsÓ
opposing signals deriving from TrkA versus p75NTR acti-
vation, and that apoptosis is triggered when the balance of
ÒdeathÓ signals deriving from p75NTR is greater than the
ÒsurvivalÓ signals deriving from TrkA. In cellular terms,
this ensures that all neurons that are incapable of seques-
tering sufficient target-derived NGF are rapidly and effi-
ciently eliminated from competition.
One final issue derives from the emerging similarities
between sympathetic neuron apoptosis as induced by
NGF withdrawal and p75NTR activation. In both cases,
the MEKK-JNK pathway is induced, and in both cases,
p53 is required for apoptosis. In the case of p75, while this
receptor has been demonstrated to signal via a number of
pathways, including ceramide production (Dobrowsky et al.,
1994), JNK activation (Casaccia-Bonnefil et al., 1996),
c-jun hyperphosphorylation (Bamji et al., 1998) and NFkB
activation (Carter et al., 1996), the results presented here
are the first to identify a required component, p53, of the
p75NTR apoptotic pathway. Given the similarities be-
tween NGF withdrawal and p75NTR activation, we pro-
pose that NGF-withdrawal-induced apoptosis may be, to a
large extent, a p75NTR-mediated process. In particular,
our previous work (Bamji et al., 1998) indicates that NGF-
withdrawal induced apoptosis of sympathetic neurons is
greatly delayed in the absence of p75NTR. We propose
that, during naturally occurring sympathetic neuron death,
p75NTR may well provide the basis for a constitutive
apoptotic signal in sympathetic neurons via one of two
different mechanisms. First, there may be an autocrine
p75NTR-dependent apoptotic loop; sympathetic neurons
synthesize BDNF (Causing et al., 1997) that they process
and secrete (Causing, C.G., R. Aloyz, and F.D. Miller, un-
published observations). Since BDNF can bind to p75NTR
to cause sympathetic neuron apoptosis (Bamji et al., 1998),
and since BDNF is required in vivo for a portion of ap-
propriate naturally occurring sympathetic neuron death
(Bamji et al., 1998), then this may indicate the presence of
an ongoing autocrine BDNF:p75NTR death signal. A sec-
ond possibility is that p75NTR functions to mediate a con-
stitutive death signal in the absence of ligand, as previ-
ously suggested (Rabizadeh et al., 1993). However, it is
clear that addition of exogenous BDNF is essential for a
maximal p75NTR-dependent apoptotic signal (Bamji et al.,
1998), indicating that even if a constitutive death mecha-
nism(s) is in place, activation of p75NTR by exogenous,
potentially target-derived, neurotrophins is likely to play a
key role. In either case, exposure to an appropriate neu-
rotrophin, in this case NGF, would lead to TrkA activa-
tion, thereby providing a mechanism for overriding p75
and p53-mediated apoptosis.
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